[Effect of an oraly used product on allergic rhinitis].
D000293:Adolescent; D002110:Caffeine / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002744:Chlorpheniramine / Q000627:therapeutic use; D004809:Ephedrine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D014663:Nasal Decongestants / Q000627:therapeutic use*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*
D014663:Nasal Decongestants; D002110:Caffeine; D002744:Chlorpheniramine; D004809:Ephedrine
Acción de un nuevo producto por via bucal sobre las rinitis alérgicas.